Zhengxiao Zhao
Overview
Explore the profile of Zhengxiao Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen B, Mao Y, Li J, Zhao Z, Chen Q, Yu Y, et al.
Comput Biol Med
. 2023 Nov;
167:107612.
PMID: 37939408
Background: Even after curative resection, the prognosis for patients with intrahepatic cholangiocarcinoma (iCCA) remains disappointing due to the extremely high incidence of postoperative recurrence. Methods: A total of 280 iCCA...
2.
Zhao Z, Bo Z, Ye N, Dong Y, Xu Y, Wang B, et al.
Liver Int
. 2023 Oct;
44(1):155-168.
PMID: 37804070
Background And Aims: Sarcopenia is associated with poor prognosis, but its role in older patients with intrahepatic cholangiocarcinoma (ICC) is unclear. We aimed to evaluate the impact of sarcopenia on...
3.
Bo Z, Chen B, Yang Y, Yao F, Mao Y, Yao J, et al.
Eur J Nucl Med Mol Imaging
. 2023 Mar;
50(8):2501-2513.
PMID: 36922449
Purpose: Postoperative early recurrence (ER) leads to a poor prognosis for intrahepatic cholangiocarcinoma (ICC). We aimed to develop machine learning (ML) radiomics models to predict ER in ICC after curative...
4.
Bo Z, Chen Z, Chen B, Yang J, Zhao Z, Yang Y, et al.
Front Nutr
. 2023 Feb;
10:1040297.
PMID: 36845061
Background: Sarcopenia has a remarkable negative impact on patients with liver diseases. We aimed to evaluate the impact of preoperative sarcopenia on the short-term outcomes after hepatectomy in patients with...
5.
Bo Z, Chen B, Zhao Z, He Q, Mao Y, Yang Y, et al.
Clin Cancer Res
. 2023 Feb;
29(9):1730-1740.
PMID: 36787379
Purpose: We aimed to construct machine learning (ML) radiomics models to predict response to lenvatinib monotherapy for unresectable hepatocellular carcinoma (HCC). Experimental Design: Patients with HCC receiving lenvatinib monotherapy at...
6.
Ma J, Bo Z, Zhao Z, Yang J, Yang Y, Li H, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765583
Background: Lenvatinib and transarterial chemoembolization (TACE) are first-line treatments for unresectable hepatocellular carcinoma (HCC), but the objective response rate (ORR) is not satisfactory. We aimed to predict the response to...
7.
Li Q, Zhang H, Yan X, Zhao Z, Qiu J, Hu L, et al.
Pulm Pharmacol Ther
. 2023 Jan;
79:102197.
PMID: 36690317
Icariin (ICA) might be a potential anti-inflammatory medication in a variety of diseases including COPD, and previous studies showed that ICA could attenuate cigarette smoke (CS)-induced inflammation by inhibiting nuclear...
8.
Li Q, Sun J, Cao Y, Liu B, Zhao Z, Hu L, et al.
Phytomedicine
. 2022 Jan;
96:153907.
PMID: 35026517
Background: Chronic obstructive pulmonary disease (COPD) is a disabling/fatal disease characterized by progressive pulmonary function decline, and there are currently few drugs that can effectively reverse the decline in lung...
9.
Zhao Z, Bo Z, Gong W, Guo Y
Int J Med Sci
. 2020 May;
17(8):995-1005.
PMID: 32410828
The inhibitor of DNA binding (Id) proteins are regulators of cell cycle and cell differentiation. Of all Id family proteins, Id1 is mostly linked to tumorigenesis, cellular senescence as well...
10.
Zhao Z, Gong W, Dong J, Liu L, Tang Z, Mohammadtursun N, et al.
J Tradit Chin Med
. 2020 Mar;
39(2):267-274.
PMID: 32186051
Objective: To verify the Traditional Chinese Medicine (TCM) theory that kidney-Qi deficiency (KQD) is considered to be the main cause of aging using cross-sectional study. Methods: Demographic and lifestyle characteristics...